Achievement: Project of Animal Genetic Engineering Micromolecule Targeted Antibody Therapy for Prevention and Treatment of Cow Mastitis

Achievement Owner: Antibenda (Ningxia) Biotechnology Co., Ltd

Introduction:Antibenda (Ningxia) Biotechnology Co., Ltd. is specialized in the research and integration of biotechnology application based on single chain antibody and other biological agents to prevent and treat cow mastitis. The technique is a needle-free injection method, which is easy to operate and does not cause secondary damage to breast tissue. Cows can continue to produce milk without abandoning milk during treatment of cow mastitis. The incidence of recessive mastitis in dairy cows can be reduced by 50%~70% and the daily milk yield can be increased by 20%~25% by using our preparation. The first phase of the project mainly serves Shanghai, Shandong, Inner Mongolia and Ningxia. The preparation has good applicability and broad market prospect.The company is in the leading position in R&D technology of antibody preparation for cow mastitis, and has formed a complete R&D and production chain of antibody biological preparation. The future development strategy planning of the enterprise mainly involves the development and production of biological products, green veterinary drugs, micro-ecological, green feed additives, etc.